Variables | Crude HR (95% CI) | P-value | Adjusted HR (95% CI) | P-value |
---|---|---|---|---|
Age, years | 0.97 [0.94–1.01] | 0.157 | 1.05 [0.97– 1.13] | 0.206 |
Females (vs males) | 0.72 [0.30–1.70] | 0.442 | 22.7 [0.87–593.88] | 0.061 |
History of MEE before diagnosis | 2.82 [1.01–7.88] | 0.048 | 1.31 [0.13–13.38] | 0.819 |
PNS abnormalities at diagnosis | 2.48 [0.73–8.50] | 0.147 | 2.8 [0.01–691.93] | 0.712 |
Major organ involvement at diagnosis | 1.89 [0.73–4.91] | 0.190 | 65.44 [1.50–2838.39] | 0.030 |
Eosinophil count at diagnosis | 1.00 [0.99–1.00] | 0.985 | 1.00 [0.99–1.00] | 0.077 |
ESR level at diagnosis | 1.02 [1.00–1.03] | 0.099 | 1.02 [1.00– 1.05] | 0.062 |
CRP lever at diagnosis | 1.03 [0.96–1.12] | 0.417 | 1.00 [0.74–1.36] | 1.000 |
Continuing the maintenance steroid without cessation | 0.48 [0.18–1.25] | 0.132 | 8.59 [1.13– 65.42] | 0.038 |
Early onset of ear symptom after systemic therapy (< 6 Months) | 4.53 [1.42–14.47] | 0.011 | 40.0 [1.35–1183.43] | 0.033 |